In 2024, total arms production volume in Ukraine amounted to $10B, which is 200% more than in 2023 and 900% more than in 2022. However, Ukrainian manufacturers are only operating at 30-40% of their capacity. The potential for growth is laid down in the plans for 2025:…
Author: admin
-
Developers in Kyiv prefer to build business-class housing, while budget residential complexes are built in the suburbs.
During the last three years of war, construction costs in Kyiv have increased by 16% annually, according to average annual indicators of the indirect cost of housing construction in Ukraine.
It is noted that the increase in the cost of construction work is due to changes…
Continue Reading
-
Trump and Putin Discuss Ukraine-Russia Cease-Fire: What to Know
President Vladimir V. Putin of Russia agreed on Tuesday during a phone call with President Trump to temporarily halt strikes on Ukrainian energy infrastructure, according to the Kremlin.
That fell short of the unconditional 30-day cease-fire that Ukraine had already agreed to, at the urging of…
Continue Reading
-
Two astronauts stuck in space for 9 months have returned to Earth
Astronauts Suni Williams and Butch Wilmore’s extended stay in the International Space Station will add to what we know about how space affects health.
Continue Reading
-
Non-genetic theories of cancer address inconsistencies in current paradigm
It’s time for researchers to reconsider the current paradigm of cancer as a genetic disease, argued Sui Huang from the Institute for Systems Biology, USA, and colleagues in a new essay published March 18 in the open-access journal PLOS Biology.
The prevailing theory on the origin of cancer is…
Continue Reading
-
Blood pressure patterns during pregnancy predict later hypertension risk, study finds
Women with blood pressure levels in a range considered clinically normal during pregnancy but no mid-pregnancy drop in blood pressure face an increased risk of developing hypertension in the five years after giving birth. These women — about 12% of the population studied — would not be flagged…
Continue Reading
-
Latest Alzheimer’s drug shown less effective in females than males
Since becoming only the second Alzheimer’s-modifying drug to gain American Federal Drug Administration approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.
In its Phase 3 clinical trial, lecanemab slowed…
Continue Reading
-
Vaccine may improve breast cancer treatment outcomes
Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen receptor-negative (HER2-positive, ER-negative) breast cancer and has shown…
Continue Reading
-
Whose air quality are we monitoring?
U.S. Environmental Protection Agency (EPA) air quality monitors are disproportionally located in predominately white neighborhoods, according to University of Utah research. The EPA’s network consistently failed to capture air quality in communities of color across six major pollutants,…
Continue Reading
-
Researchers find missing link in autoimmune disorder
Autoimmune diseases, which are estimated to affect more than 15 million people in the U.S., occur when the body responds to immune-system false alarms, and infection-fighting first responders are sent out to attack threats that aren’t there. Scientists have long understood how the false alarms…
Continue Reading